{"id":1112991,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis:A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-28","captureTimestamp":"2026-02-28T19:02:13.180000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54083.html?wbdisable=false","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis: A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) Summary SGLT2 inhibitor use was associated with an increased risk of DKA compared to DPP-4 inhibitors among patients with…","rawSnapshotUrl":"/api/snapshots/raw/1112991","browseUrl":"https://replay.healtharchive.ca/job-8/20260228190213/https://cihr-irsc.gc.ca/e/54083.html?wbdisable=false#ha_snapshot=1112991","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}